Hand-out
Press Releases
November 5, 2024
Taiho Oncology to Present Data at the 66th American Society of Hematology Annual Meeting
Data to be presented from an oral azacitidine plus cedazuridine (ASTX030) combination phase 1 open-label dose escalation and expansion trialFindings to be shared from a study analyzing real–world use patterns
